Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Rheumatology

• Publication date

  2007-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 17696269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hyperuricemia as a risk factor for cardiovascular mortality.

  2009cited by this paper
• Hyperuricaemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden.

  2009cited by this paper
• Uric acid and cardiovascular risk.

  2009cited by this paper
• Gout and the risk of acute myocardial infarction.

  2006cited by this paper
• Recent developments in diet and gout

  2006cited by this paper
• Relations of Serum Uric Acid to Longitudinal Blood Pressure Tracking and Hypertension Incidence

  2005cited by this paper
• The insulin resistance syndrome: definition and dietary approaches to treatment.

  2005cited by this paper
• Metabolic syndrome.

  2005cited by this paper
• Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

  2005cited by this paper
• Hyperuricemia induces endothelial dysfunction.

  2005cited by this paper
• Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

  2005cited by this paper
• Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle

  2004cited by this paper
• The Use of Antiepileptic Drugs—Principles and Practice

  2004cited by this paper
• Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm.

  2004cited by this paper
• Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia.

  2004cited by this paper
• Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study.

  2004cited by this paper
• Author Contributions: JGW, KDMJ,

  2004cited by this paper
• Uric acid: role in cardiovascular disease and effects of losartan

  2004cited by this paper
• Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men

  2004cited by this paper
• Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?

  2003cited by this paper
• The metabolic syndrome.

  2003cited by this paper
• Serum Urate as an Independent Predictor of Poor Outcome and Future Vascular Events After Acute Stroke

  2003cited by this paper
• Uric acid and cardiovascular risk.

  2002cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP)

  2000cited by this paper
• Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey.

  2000cited by this paper
• Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study

  1999cited by this paper
• Second Manifestations of ARTerial disease (SMART) study: Rationale and design

  1999cited by this paper
• Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus.

  1998cited by this paper
• [Hyperuricemia and insulin resistance].

  1996cited by this paper
• Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study.

  1995cited by this paper
• Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study.

  1995cited by this paper
• Hyperuricemia and insulin resistance.

  1994cited by this paper
• Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration.

  1991cited by this paper
• Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry.

  1989cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper
• Contemporary Reviews in Cardiovascular Medicine Metabolic Syndrome A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation

  year unknowncited by this paper

• Association Between Uric Acid to High-Density Lipoprotein Cholesterol Ratio and Abdominal Aortic Aneurysm: A Single-Center Retrospective Study

  2025cites this paper
• Hyperuricaemia and metabolic syndrome

  2025cites this paper
• URAT1 and GLUT9 as drug targets in gout: progress in transporter-directed therapies and delivery technologies

  2025cites this paper
• Association between uric acid and aortic aneurysms: A two-sample Mendelian randomization study

  2025cites this paper
• Association between sedentary behavior, hyperuricemia, and gout in American adults: a nationally representative cross-sectional study

  2025cites this paper
• A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease

  2024cites this paper
• The serum uric acid/high-density lipoprotein cholesterol ratio: a novel predictor for the presence of abdominal aortic aneurysm

  2024cites this paper
• Association of hyperuricemia with cardiovascular diseases: current evidence

  2023cites this paper
• Narrative Review: Peripheral Arterial Disease in Patients with Hyperuricemia and Gout

  2023cites this paper
• Evaluation of the Relationship Between Thrombolytic Treatment Complications and Laboratory Parameters in Acute Ischemic Stroke Patients

  2022cites this paper
• Gender difference in the association between gout at diagnosis and metabolic syndrome in African population: a retrospective cohort study

  2022cites this paper
• Association between uric acid levels and incidence of type 2 diabetes: Population-based Panasonic cohort study 11.

  2022cites this paper
• Hyperuricemia during Pregnancy Leads to a Preeclampsia-Like Phenotype in Mice

  2022cites this paper
• Glucose Transporter 9 (GLUT9) Plays an Important Role in the Placental Uric Acid Transport System

  2022cites this paper
• Meta-analysis for the Relationship Between Hyperuricemia and CVD Incidence

  2021cites this paper
• Monocyte-to-HDL-cholesterol ratio is associated with Ascending Aorta Dilatation in Patients with Bicuspid Aortic Valve

  2021cites this paper
• Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease

  2021cites this paper
• Semiparametric Bayes instrumental variable estimation with many weak instruments

  2021cites this paper
• Release of uric acid from poly(ɛ-caprolactone) nanofibers as potential treatment for spinal cord injury

  2020cites this paper
• A Retrospective, Cross-Sectional Study on the Prevalence of Hyperuricemia Using a Japanese Healthcare Database.

  2020cites this paper
• Role of Uric Acid in Coronary Artery Disease

  2020cites this paper
• Different Pharmacological Properties of GLUT9a and GLUT9b: Potential Implications in Preeclampsia.

  2019cites this paper
• Association Of Non-Alcoholic Fatty Liver Disease With Serum Uric Acid.

  2018cites this paper
• Interrelationship of Uric Acid, Gout, and Metabolic Syndrome: Focus on Hypertension, Cardiovascular Disease, and Insulin Resistance

  2018cites this paper
• Allopurinol and the risk of incident peripheral arterial disease in the elderly: a US Medicare claims data study

  2018cites this paper
• Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study.

  2018cites this paper
• Allopurinol and the risk of incident peripheral arterial disease in the elderly: a US Medicare claims data study

  2018cites this paper
• THE METABOLIC DISTURBANCE OF IRON AND CALCIUM-CHARACTERISTIC METABOLIC FACTOR OF THE PATHOGENESIS OF DENTAL AND GENERAL SOMATIC COMORBID PATHOLOGY

  2018influential citation
• Physiological functions and pathogenic potential of uric acid: A review

  2017cites this paper
• Assessing the impact of gout

  2017cites this paper
• Non-Alcoholic Fatty Liver Disease, Hyperuricemia and Carotid Intima-Medial Thickness: A Case Control Study

  2016cites this paper
• Benchmark dose of alcohol consumption for development of hyperuricemia in Japanese male workers: An 8-year cohort study.

  2016cites this paper
• Prevalence and factors associated with hyperuricaemia in newly diagnosed and untreated hypertensives in a sub-Saharan African setting.

  2016cites this paper
• Relationship between Hyperuricemia, Hyperglycemia and Elevated Triglyceride Levels in Cardiometabolic Disorder

  2016cites this paper
• A Greater Association of Hyperuricemia than of Metabolic Syndrome with the New Incidence of Chronic Kidney Disease

  2016cites this paper
• Association of the serum uric acid level with liver histology in biopsy-proven non-alcoholic fatty liver disease.

  2016cites this paper
• Cost of Illness and Determinants of Costs Among Patients with Gout

  2015cites this paper
• Mid-gestational serum uric acid concentration effect on neonate birth weight and insulin resistance in pregnant women

  2015cites this paper
• Increased catabolism of nucleic acid in nonalcoholic fatty liver disease patients of different ages.

  2014cites this paper
• Comorbidities in patients with crystal diseases and hyperuricemia.

  2014cites this paper
• Hyperuricaemia and gout in New Zealand rural and urban Māori and non‐Māori communities

  2013cites this paper
• Resource Use and Economic Impact of Patients With Gout: A Multicenter, Population-Wide Study

  2013cites this paper
• The Prevalence and Risk Factors for Gout

  2013cites this paper
• Resource use and economic impact of patients with gout: a multicenter, population-wide study.

  2013cites this paper
• Management of Hyperuricemia and Gout

  2013cites this paper
• Increased uric acid promotes decline of the renal function in hypertensive patients: a 10-year observational study.

  2013cites this paper
• Hyperuricemia and Cardiovascular Disease: Is This Relationship Independent of the Etiology of Hyperuricemia?

  2013cites this paper
• The Correlation of Maternal Uric Acid Concentration with Small-for-Gestational-Age Fetuses in Normotensive Pregnant Women

  2012cites this paper
• Prevalence and Clinical Features of Hyperuricemia in Gwangju and Jeonnam Territories

  2012cites this paper
• Ácido úrico y síndrome metabólico en una población masculina de pilotos de líneas aéreas

  2012cites this paper
• Estudio de pacientes con gota: características clínicas en los últimos 2 años de seguimiento

  2012cites this paper
• [Survival of gout patients].

  2012cites this paper
• [Study of patients with gout: clinical features in the last 2 years of monitoring].

  2012cites this paper
• Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses.

  2012cites this paper
• Epidemiology of gout and chondrocalcinosis.

  2012cites this paper
• Rapid effects of pitavastatin on uric acid homeostasis

  2011cites this paper
• Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?

  2011cites this paper
• Otros factores asociados con síndrome metabólico

  2011cites this paper
• The association of uric acid with glucose and lipids in general population: Croatian cross-sectional study.

  2011cites this paper
• Uric Acid Metabolism in Patients with Primary Gout and the Metabolic Syndrome

  2010cites this paper
• High Serum Uric Acid Increases the Risk for Nonalcoholic Fatty Liver Disease: A Prospective Observational Study

  2010cites this paper
• Relation of uric acid levels to aortic root dilatation in hypertensive patients with and without metabolic syndrome

  2010cites this paper
• Epidemiology of gout: an update.

  2010cites this paper
• Gout: an independent risk factor for all-cause and cardiovascular mortality.

  2010cites this paper
• Metabolic Syndrome Characteristics in Gout Patients

  2010cites this paper
• Solute carrier family 2, member 9 and uric acid homeostasis

  2009cites this paper
• What Rheumatologists Should Know About Gout and Cardiovascular Disease

  2009cites this paper
• Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study.

  2009cites this paper
• Concise report Gout: an independent risk factor for all-cause and cardiovascular mortality

  2009cites this paper
• Role of metabolic syndrome components in human immunodeficiency virus-associated stroke

  2009cites this paper
• Hyperuricemia, gout and the metabolic syndrome

  2008cites this paper